A magnetically recoverable carbon nitride–iron oxide photocatalyst removed 91.25 percent of rhodamine B under visible light ...
Peer-reviewed study published in the HCA Healthcare Journal of Medicine reports Phase 2 interim results of 90.0% sensitivity, 87.3% specificity and an AUC-ROC of 0.959 using a post hoc balanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results